Affiliations 

  • 1 Department of Biochemistry, Bahauddin Zakariya University, Multan 60800, Pakistan
  • 2 Department of Basic Sciences, University of Veterinary and Animal Sciences Lahore, Narowal Campus, Narowal 51600, Pakistan
  • 3 Institute of Chemical Sciences, Bahauddin Zakariya University, Multan 60800, Pakistan
  • 4 Department of Clinical Sciences, University of Veterinary and Animal Sciences Lahore, Narowal Campus, Narowal 51600, Pakistan
  • 5 Department of Chemistry, Khwaja Fareed University of Engineering & Information Technology, Rahim Yar Khan 64200, Pakistan
  • 6 Basic Sciences and Oral Biology Unit, School of Dental Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian 16150, Kelantan, Malaysia
  • 7 Department of Pharmacy, Pak-Austria Fachhochschule Institute of Applied Sciences and Technology, Mang, Haripur 22620, Khyber Pakhtunkhwa, Pakistan
  • 8 Department of Infectious Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China
Oxid Med Cell Longev, 2022;2022:2100092.
PMID: 36466089 DOI: 10.1155/2022/2100092

Abstract

The poor solubility of the antidiabetic drug gliclazide (Glc) is due to its hydrophobic nature. This research is aimed at improving Glc's solubility and drug release profile, as well as at investigating additional benefits such as bioactivity and antioxidant activity, by forming binary complexes with HPβCD at different w/w ratios (1 : 1, 1 : 2.5, 1 : 4, and 1 : 9) and ternary complexes with HPβCD and Tryp at 1 : 1 : 1, 1 : 1 : 0.27, 1 : 2.5 : 0.27, 1 : 3.6 : 3.6, 1 : 4 : 1, and 1 : 9 : 1, respectively. Complexes were prepared by the physical mixing (PM) and solvent evaporation (SE) methods. The prepared inclusion complexes were meticulously characterized by X-ray diffractometry (XRD), scanning electron microscopy (SEM), and attenuated total reflectance-Fourier transform infrared (ATR-FTIR) spectra. To verify our findings, the inclusion complexes were evaluated by equilibrium solubility, in vitro drug release profile, kinetic models, and antidiabetic and antioxidant activities in animal models. Our results demonstrated that the solubility and drug release profile were found to be enhanced through binary as well as ternary complexes. Notably, ternary complexes with a ratio of 1 : 9 : 1 showed the highest solubility and drug release profile compared to all other preparations. Data on antioxidant activity indicated that the ternary complex had the higher total antioxidant status (TAS), superoxide dismutase (SOD), and catalase (CAT) activity than the binary complex and Glc alone, in contrast to the diabetic group. In vivo antidiabetic activity data revealed a high percentage reduction in the blood glucose level by ternary complexes (49-52%) compared to the binary complexes (45-46%; p ≤ 0.05). HPβCD and Tryp provide a new platform for overcoming the challenges associated with poorly soluble Glc by providing greater complexing and solubilizing capabilities and imparting ancillary benefits to improve the drug's antidiabetic and antioxidant activities.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.